Taken together, these results suggest that in the ob/ob-MASH model, semaglutide and resmetirom were equally effective in improving MASH symptoms, with semaglutide having an ameliorative effect on liver fibrosis while resmetirom did not
Injecting into the same site repeatedly is among the most common mistakes, leading to tissue damage, discomfort, and increased injection-site reactions
With limited data for recommended guidelines, professional associations and societies are releasing clinical practice updates and considerations for safe patient care
CrossRef Alcohol-driven phenotypic transition in MASLD and risk of liver-related events Seohui Jang, Jihun Song, Eun Seok Kang, Sangwook Cheon, Taeho Kwak, Yihyun Kim, Seokjin Kong, Jinhyeok Choi, Minjeong Kang, Jaewon Khil, Hye Jun Kim, Jeongin Lee, Hwamin Lee, Seogsong Jeong JHEP Reports .2026